Lux Biosciences' Series B Round

Lux Biosciences raised a round of funding on October 21, 2009.

Lux Biosciences is a clinical stage biotechnology company specializing in the development and commercialization of medications for serious ophthalmic diseases. With a product in NDA/MAA submission sta…

Articles about Lux Biosciences' Series B Round: